- Home
- BRNS vs LOAN Comparison
BRNS vs LOAN Comparison
Compare BRNS & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRNS | LOAN |
|---|---|---|
| Founded | 2016 | 1989 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9M | 51.9M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BRNS | LOAN |
|---|---|---|
| Price | $0.62 | $4.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 59.9K | 20.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.89% |
| EPS Growth | ★ 18.85 | 2.08 |
| EPS | N/A | ★ 0.35 |
| Revenue | ★ $14,969,000.00 | $9,688,641.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $12.63 |
| Revenue Growth | ★ 1766.46 | N/A |
| 52 Week Low | $0.56 | $4.29 |
| 52 Week High | $2.91 | $6.05 |
Technical Indicators
Market Signals| Indicator | BRNS | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 38.07 | 36.28 |
| Support Level | $0.56 | $4.38 |
| Resistance Level | $0.76 | $4.59 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 12.11 | 15.33 |
Price Performance
Historical ComparisonAbout BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.